3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
31
Colorectal Neoplasms
18
Carcinoma, Hepatocellular
18
Stomach Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Squamous Cell Carcinoma of Head and Neck
9
Neoplasm Metastasis
9
Advanced Solid Tumor
9
Lung Neoplasms
7
Head and Neck Neoplasms
7
Rectal Neoplasms
5
Esophageal Neoplasms
5
Small Cell Lung Carcinoma
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Melanoma
4
Solid Tumor
3
Lymphoma, Follicular
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Biliary Tract Neoplasms
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma
2
Hodgkin Disease
2
Interventions
fludarabine
52
Cyclophosphamide
50
venetoclax
48
Azacitidine
46
fludarabine phosphate
41
Whole-Body Irradiation
33
Specimen Handling
31
Mycophenolic Acid
30
Tacrolimus
28
Melphalan
28
Busulfan
27
Cytarabine
25
Stem Cell Transplantation
23
Decitabine
23
Biopsy
22
Granulocyte Colony-Stimulating Factor
19
Sirolimus
16
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Thiotepa
15
decitabine and cedazuridine drug combination
14
Injections
14
Cyclosporine
13
ruxolitinib
9
Methotrexate
9
Mesna
9
Hematopoietic Stem Cell Transplantation
9
X-Rays
8
Idarubicin
8
Daunorubicin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
tislelizumab
×
1 year
×
Clear all
No trials found.